Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

I think the Rolontis same day dosing Poster could give the stock a boost if it's positive since that label would really differentiate Rolontis from the others it's competing against. It would take 2 years or so to run the trial and get approval but the Street is forward looking. Since the SP is inching up, I suspect that might be the case although it could be inching up on expectations of a pozi NDA green light announcement too. We'll see.

Having said that I am just as interested in the Poster for the pozi BC trial. My expectation before we realized higher dosing compared to the Korean BC trial could cause patients to stop taking the drug was that w higher dosing you'd see more efficacy. If that was the case we would have seen these results a year ago so that didn't happen but am still very interested in seeing these results. And regarding the Rolontis P3 trials, well we've seen it before.